Ashish Mandelia

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Ashish Mandelia
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ashish Mandelia:

Company Role Class Num Shares Value Price $ Report Date Ownership
Mersana Therapeutics, Inc. VP, Chief Accounting Officer Restricted Stock Units 0 $45,168 $2.71 06 Jan 2026 Direct
Mersana Therapeutics, Inc. VP, Chief Accounting Officer Restricted Stock Unit 16,667 $9,667 $0.5800 15 Jan 2025 Direct
Mersana Therapeutics, Inc. VP, Chief Accounting Officer Common Stock 0 $0 $28.14 06 Jan 2026 Direct
Mersana Therapeutics, Inc. VP, Chief Accounting Officer Stock Option (right to buy) 0 06 Jan 2026 Direct

Insider Reports Filed by Ashish Mandelia

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MRSN Mersana Therapeutics, Inc. 06 Jan 2026 18 $0 4 VP, Chief Accounting Officer 06 Jan 2026, 16:44
MRSN Mersana Therapeutics, Inc. 15 Jan 2025 7 -$2,061 4 VP, Chief Accounting Officer 17 Jan 2025, 19:27
MRSN Mersana Therapeutics, Inc. 14 Jan 2025 3 -$1,128 4 VP, Chief Accounting Officer 16 Jan 2025, 17:25
MRSN Mersana Therapeutics, Inc. 13 Jan 2025 3 -$665 4 VP, Chief Accounting Officer 15 Jan 2025, 21:19
MRSN Mersana Therapeutics, Inc. 01 Oct 2024 4 -$16,298 4 VP, Chief Accounting Officer 07 Oct 2024, 17:47
MRSN Mersana Therapeutics, Inc. 13 Jan 2024 0 $0 4/A VP, Chief Accounting Officer 16 Feb 2024, 16:30
MRSN Mersana Therapeutics, Inc. 13 Jan 2024 11 -$13,618 4 VP, Chief Accounting Officer 17 Jan 2024, 17:20
MRSN Mersana Therapeutics, Inc. 05 Sep 2023 1 $0 4 VP, Chief Accounting Officer 07 Sep 2023, 18:55
MRSN Mersana Therapeutics, Inc. 13 Jan 2023 9 -$20,520 4 VP, Controller 18 Jan 2023, 19:20
MRSN Mersana Therapeutics, Inc. 14 Jan 2022 6 -$11,733 4 VP, Controller 19 Jan 2022, 17:19
MRSN Mersana Therapeutics, Inc. 01 Jul 2021 1 -$12,811 4 VP, Controller 02 Jul 2021, 16:31